Toggle navigation
Kaspar Rufibach
Home
Publications
Textbook
Software
Talks
Teaching & supervision
Working groups
MIRROS: Phase 3 trial with time-to-event endpoint, cure proportion, and futility interim analysis using response
Date
Apr 2, 2019
00:00 — 00:00
Event
SMi conference on adaptive clinical trials (invited talk)
Location
London, UK
Links
Slides
←
Estimand framework in Oncology drug development -- impact and opportunities
External controls in drug development (with Hans Ulrich Burger)
→
×
Cite